AKT inhibitor VIII is a cell-permeable and reversible quinoxaline compound that potently and selectively inhibits Akt1/Akt2 activity (IC50 = 58 nM, 210 nM, and 2.12 ?M for Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays).
More Information Supplier PageAKT inhibitor VIII is a cell-permeable and reversible quinoxaline compound that potently and selectively inhibits Akt1/Akt2 activity (IC50 = 58 nM, 210 nM, and 2.12 ?M for Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays).
More Information Supplier PageCefozopran is a fourth-generation cephalosporin. It would be effective against respiratory tract, urinary tract, and soft tissue infections caused by a variety of gram-positive and gram-negative bacteria in humans.
More Information Supplier PageCefozopran is a fourth-generation cephalosporin. It would be effective against respiratory tract, urinary tract, and soft tissue infections caused by a variety of gram-positive and gram-negative bacteria in humans.
More Information Supplier PageIPI-493 is a potent and orally bioavailable HSP90 inhibitor with Ki of 21 nM.
More Information Supplier PageIPI-504 is a novel, water-soluble, potent inhibitor of heat-shock protein 90 (Hsp90).
More Information Supplier PageIPI-504 is a novel, water-soluble, potent inhibitor of heat-shock protein 90 (Hsp90).
More Information Supplier PageIPI-504 is a novel, water-soluble, potent inhibitor of heat-shock protein 90 (Hsp90).
More Information Supplier PageIPI-504 is a novel, water-soluble, potent inhibitor of heat-shock protein 90 (Hsp90).
More Information Supplier PageOdanacatib is an inhibitor of cathepsin K,an enzyme involved in bone resorption.
More Information Supplier Page
